Respiratory syncytial virus PREVENT Study questions.
Dransfield
D
D
Kessler
D
D
McCarthy
C
C
D003362:Cost-Benefit Analysis; D006760:Hospitalization; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D007902:Length of Stay / Q000706:statistics & numerical data; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012306:Risk; D013223:Statistics as Topic
D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous